Snapshot · Cigna Corporation (CI)
Sector: Healthcare / Medical - Healthcare Plans
Data as of 2026-09-01T22:28:48.784Z
Fundamentals check
- Market cap
- $74.8B
- P/E (TTM)
- 11.7
- Gross margin
- 11.7%
- Net margin
- 2.3%
- ROE
- 15.2%
- R&D / revenue
- 0.0%
- Dividend yield
- 2.2%
- FCF yield
- 12.2%
Latest dividend: $1.56/share (ex-date 2026-09-08, quarterly)
Summary
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
How it makes money
Revenue mix, latest fiscal year
- Evernorth83.2%
- Cigna Healthcare16.8%
Recent Events
- 2026-08-31T10:41:24.000Zneutral
Here's Why Cigna (CI) is a Strong Value Stock
分析文章指出价值特征,可能与市场情绪波动相关,但并非直接因果。
Source: zacks.com
- 2026-08-29T04:08:47.000Zpositive
Beacon Pointe Advisors LLC Buys Shares of 39,957 Cigna Group $CI
机构买入可能与股价波动相关,恰逢持仓调整的信号,存在不确定性。
Source: defenseworld.net
- 2026-08-27T14:20:00.000Zneutral
Can Cigna's Smart Coverage Help Close Health-Cost Gaps?
新福利概念可能提升长期参与度,可能与成本相关性相关,尚不确定对股价的直接影响。
Source: Zacks Investment Research
- 2026-08-26T07:00:00.000Zpositive
Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs
连接福利体验的推出可能有助于缓解成本压力,可能与长期销售及现金流相关,存在不确定性。
Source: prnewswire.com
- 2026-08-25T05:40:13.000Zneutral
Zacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina
行业展望报道可能与行业趋势相关,非直接因果,需结合其他信息判断影响。
Source: zacks.com
- 2026-08-25T05:21:47.000Zneutral
Barrow Hanley Mewhinney & Strauss LLC Acquires New Position in Cigna Group $CI
大额基金增持可能与市场情绪相关,但不构成直接因果,需进一步观察。
Source: defenseworld.net
- 2026-08-24T10:46:11.000Zpositive
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
增长前景的分析可能提升投资者兴趣,尚未构成因果性结论。
Source: zacks.com
- 2026-08-19T12:46:21.000Zneutral
Here's Why Investors Should Stay Neutral on Cigna Stock for Now
中性观点表明当前不确定性较高,非直接因果。
Source: zacks.com
- 2026-08-17T08:00:00.000Zpositive
Cigna: I'm Buying What Others Are Ignoring
买入观点反映乐观,但不构成因果推断,需警惕市场情绪。
Source: seekingalpha.com
- 2026-08-15T03:21:24.000Zneutral
Banyan Capital Management Inc. Decreases Stock Holdings in Cigna Group $CI
减持公告可能与投资组合再平衡相关,非直接因果。
Source: defenseworld.net
- 2026-08-12T10:41:35.000Zpositive
Cigna (CI) is a Top Value Stock for the Long-Term
长期价值属性的分析可能提升投资者兴趣,存在不确定性。
Source: zacks.com
- 2026-08-12T10:41:35.000Zpositive
Why Cigna (CI) is a Top Value Stock for the Long-Term
长期价值观点可能与投资者情绪相关,包含不确定性。
Source: zacks.com
- 2026-08-07T10:46:13.000Zpositive
Here's Why Cigna (CI) is a Strong Growth Stock
成长性分析可能提升兴趣,非直接因果。
Source: zacks.com
- 2026-08-01T03:48:02.000Znegative
Cigna Group $CI Stock Holdings Lifted by Bank of America Corp DE
银行持股增加可能与市场资金流动相关,未必直接驱动价格方向。
Source: defenseworld.net
- 2026-07-31T10:36:12.000Zneutral
Cigna's Valuation Gap Still Stands Out
估值差距分析可能与投资者情绪相关,但非因果结论。
Source: seekingalpha.com
- 2026-07-30T00:00:00.000Znegative
CI filed 10-Q
CI 10-Q 的披露可能与收益、指引等相关,恰逢市场对公司更新关注,存在不确定性。
Source: SEC EDGAR
- 2026-07-16T00:00:00.000Znegative
Price move: CI fell 4.7%
CI 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。
- 2026-07-02T00:00:00.000Zpositive
Price move: CI rose 3.9%
CI 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。
- 2026-06-04T00:00:00.000Zpositive
Price move: CI rose 3.7%
CI 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。
Price & event timeline
Price & event timeline
Three months of price history with annotated events to help spot what may have driven a move.
筹码分布
资金流指标
以下为基于公开量价数据的技术指标估算,非真实主力资金流。
Analyst view
Wall Street ratings
Avg price target $336.63 from 8 analysts (last quarter)
Insider & Congress activity
聪明钱动向 · 近 90 天
内部人近 90 天整体偏卖出,国会议员披露无相关交易。
Open-market trades only; grants and exercises excluded
- 2026-08-18SellJones Nicole S(officer: See Remarks)2,677 shares
- 2026-08-04SellJones Nicole S(officer: See Remarks)19,436 shares
- 2026-06-12SellKates Jamie G(officer: Chief Accounting Officer)899 shares
US Congress trading disclosures
- 2026-03-27Alan ArmstrongPurchase$1,001 - $15,000
Go deeper
订阅每日简报
每个交易日开盘/收盘后,中文市场简报直达邮箱。免费,随时退订。
本内容仅为信息整理,不构成任何投资建议。
Deep analysis
Deep analysis
Generate a full in-page analysis (business model, risks, scenarios). Not investment advice.